REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorios Novandina del Ecuador S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Laboratorios Novandina del Ecuador S.A. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Laboratorios Novandina del Ecuador S.A. is an enterprise in Ecuador, with the main office in Quito. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on August 23, 2012. The total number of employees is currently 4 (2024). In 2024, the company reported a net sales revenue increase of 16.5%. Its total assets grew by 74.2% over the same period.

Headquarters
Calle Manuel Cordova Galarza, Oe4 175
Quito; Pichincha;

Contact Details: Purchase the Laboratorios Novandina del Ecuador S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Novandina del Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Laboratorios Novandina del Ecuador S.A. report to view the information.
Financial Auditors:
Purchase the Laboratorios Novandina del Ecuador S.A. report to view the information.
Incorporation Date:
August 23, 2012
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Laboratorios Novandina del Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
16.5%▲
Total operating revenue
16.5%▲
Operating profit (EBIT)
72.62%▲
EBITDA
72.62%▲
Net Profit (Loss) for the Period
N/A
Total Assets
74.2%▲
Total Equity
77.63%▲
Operating Profit Margin (ROS)
15.15%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.04%▲
Cash Ratio
0%

Similar companies

Quifatex S.A.
 
Laboratorios Siegfried S.A.
Roche Ecuador S.A.
 
Bayer S.A.
Nefrocontrol S.A.
 
Novartis Ecuador S.A.
Casa Industrial Farmaceutica S.A. Cifsa
 
Amigpharm S.A.
Krismaric Soluciones Medicas Integrales S.A.
 
Eli Lilly Interamerica Inc.
Compania Servimed Asr Cia.Ltda
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo